User profiles for Ilaria Vicenti
 | Ilaria VicentiResearch Fellow in Microbiology, university of Siena Verified email at unisi.it Cited by 1278 |
SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19
Introduction: The current SARS-CoV-2 pandemic urgently demands for both prevention and
treatment strategies. RNA-dependent RNA-polymerase (RdRp), which has no counterpart in …
treatment strategies. RNA-dependent RNA-polymerase (RdRp), which has no counterpart in …
[HTML][HTML] Targeting the RdRp of emerging RNA viruses: the structure-based drug design challenge
The RNA-dependent RNA polymerase (RdRp) is an essential enzyme for the viral replication
process, catalyzing the viral RNA synthesis using a metal ion-dependent mechanism. In …
process, catalyzing the viral RNA synthesis using a metal ion-dependent mechanism. In …
[HTML][HTML] Molecular tracing of SARS-CoV-2 in Italy in the first three months of the epidemic
A Lai, A Bergna, S Caucci, N Clementi, I Vicenti… - Viruses, 2020 - mdpi.com
The aim of this study is the characterization and genomic tracing by phylogenetic analyses
of 59 new SARS-CoV-2 Italian isolates obtained from patients attending clinical centres in …
of 59 new SARS-CoV-2 Italian isolates obtained from patients attending clinical centres in …
[HTML][HTML] SARS-CoV-2 infection of human ovarian cells: a potential negative impact on female fertility
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may affect female
reproductive health. Here, we investigated the potential of SARS-CoV-2 to infect the follicular …
reproductive health. Here, we investigated the potential of SARS-CoV-2 to infect the follicular …
[HTML][HTML] The combination of molnupiravir with nirmatrelvir or GC376 has a synergic role in the inhibition of SARS-CoV-2 replication in vitro
Introduction: The development of effective vaccines has partially mitigated the trend of the
SARS-CoV-2 pandemic; however, the need for orally administered antiviral drugs persists. …
SARS-CoV-2 pandemic; however, the need for orally administered antiviral drugs persists. …
[HTML][HTML] Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID …
I Vicenti, M Basso, F Gatti, R Scaggiante… - International Journal of …, 2021 - Elsevier
Objectives This study aimed to describe the longitudinal evolution of neutralizing antibody
titres (NtAb) in three different cohorts of healthcare workers (HCWs), including vaccinated …
titres (NtAb) in three different cohorts of healthcare workers (HCWs), including vaccinated …
Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro
A strong correlation between Zika virus (ZIKV) infection and severe neurological disease in
newborns and occasionally adults has emerged in the Brazilian outbreak. Efficient human …
newborns and occasionally adults has emerged in the Brazilian outbreak. Efficient human …
[HTML][HTML] Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or …
I Vicenti, F Gatti, R Scaggiante, A Boccuto… - International Journal of …, 2021 - Elsevier
Objectives To measure SARS-CoV-2 neutralizing antibody (NtAb) titres in previously infected
or uninfected health care workers who received one or two doses of BNT162b2 mRNA …
or uninfected health care workers who received one or two doses of BNT162b2 mRNA …
Naturally occurring hepatitis C virus (HCV) NS3/4A protease inhibitor resistance-related mutations in HCV genotype 1-infected subjects in Italy
I Vicenti, A Rosi, F Saladini, G Meini… - Journal of …, 2012 - academic.oup.com
Objectives To assess the prevalence of hepatitis C virus (HCV) NS3/4A protease inhibitor (PI)
resistance mutations in HCV genotype 1-infected PI-naive individuals in Italy. Patients and …
resistance mutations in HCV genotype 1-infected PI-naive individuals in Italy. Patients and …
[HTML][HTML] Efficacy of licensed monoclonal antibodies and antiviral agents against the SARS-CoV-2 Omicron sublineages BA. 1 and BA. 2
Newly emerging SARS-CoV-2 variants may escape monoclonal antibodies (mAbs) and
antiviral drugs. By using live virus assays, we assessed the ex vivo inhibition of the B.1 wild-type …
antiviral drugs. By using live virus assays, we assessed the ex vivo inhibition of the B.1 wild-type …